January 4th, 2016 · Common Contracts · 54 similar Bavarian Nordic a/S / ADR – BAVARIAN NORDIC A/S INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is effective as of 8 December 2015, by and between Bavarian Nordic A/S, a corporation incorporated under the laws of Denmark (the “Company”), and [name] (“Indemnitee”). [However, this Agreement is conditional on approval by the Company’s Annual General Meeting on 20 April 2016. When approved the Agreement shall have retroactive effect from 8 December 2015.](1)
This Indemnification Agreement (this “Agreement”) is effective as of 8 December 2015, by and between Bavarian Nordic A/S, a corporation incorporated under the laws of Denmark (the “Company”), and [name] (“Indemnitee”). [However, this Agreement is conditional on approval by the Company’s Annual General Meeting on 20 April 2016. When approved the Agreement shall have retroactive effect from 8 December 2015.](1)
March 1st, 2005 · Common Contracts · 4 similar Digital Angel Corp – EMPLOYMENT AGREEMENT THIS AGREEMENT (“Agreement”), made and entered into as of February 28, 2005, by and between DAPLOMA INTERNATIONAL A/S, a Danish corporation (“Company”) and TORSTEN NORDFJELD (“Executive”).
THIS AGREEMENT (“Agreement”), made and entered into as of February 28, 2005, by and between DAPLOMA INTERNATIONAL A/S, a Danish corporation (“Company”) and TORSTEN NORDFJELD (“Executive”).
April 9th, 2021 · Common Contracts · 3 similar Valneva SE – DISTRIBUTION AGREEMENT Valneva Sweden AB, [***], organized under the laws of Sweden, with its registered office at SE-105 21 Stockholm, Sweden, hereinafter referred to as “SUPPLIER”,
Valneva Sweden AB, [***], organized under the laws of Sweden, with its registered office at SE-105 21 Stockholm, Sweden, hereinafter referred to as “SUPPLIER”,
January 12th, 2016 · Common Contracts · 3 similar Bavarian Nordic a/S / ADR – COLLABORATION and LICENSE AGREEMENT between CRUCELL HOLLAND B.V. and BAVARIAN NORDIC A/S CRUCELL HOLLAND B.V., a Dutch company with offices located at Archimedesweg 4, 2333 CN Leiden, the Netherlands, (hereinafter “Crucell”);
CRUCELL HOLLAND B.V., a Dutch company with offices located at Archimedesweg 4, 2333 CN Leiden, the Netherlands, (hereinafter “Crucell”);
December 29th, 2006 · Common Contracts · 3 similar Eurotrust a/S – Agreement" Shall mean this share purchase agreement and all exhibits attached hereto, each of which constitutes an integral part of this Agreement.
February 2nd, 2000 · Common Contracts · 2 similar SBC Communications Inc – ARTICLE IV REPRESENTATIONS AND WARRANTIES OF SELLER 8 Section 4.1 Authorisation 8 Section 4.2 No Violation 8 Section 4.3 Approvals, Consents, Etc. 8 Section 4.4 Title to Sale Shares 8 Section 4.5 No Claims, Proceedings, Etc. 8
March 10th, 2010 · Common Contracts · 2 similar Danfoss Acquisition Inc – FACILITIES AGREEMENT Dated 4 February 2008 Where for such purposes, “Leverage Ratio” or “x” means the ratio of Consolidated Net Interest Bearing Debt to Consolidated EBITDA.
Where for such purposes, “Leverage Ratio” or “x” means the ratio of Consolidated Net Interest Bearing Debt to Consolidated EBITDA.
June 3rd, 2005 · Common Contracts · 2 similar Eurotrust a/S – EX-4.5 EMPLOYMENT AND SERVICE AGREEMENT EMPLOYMENT AND SERVICE AGREEMENT between EuroTrust A/S, a corporation established under the laws of the Kingdom of Denmark, with offices at Poppelgardvej 11-13 2860 Soborg, Denmark, (the "Company") and Aldo...
October 26th, 2021 · Common Contracts · 2 similar IO Biotech, Inc. – ASSIGNMENT AGREEMENT BETWEEN HERLEV AND GENTOFTE HOSPITAL AND IO BIOTECH ApS have entered into this assignment agreement regarding the assignment by the Hospital to the Company of certain intellectual property rights on the terms and conditions set out in the following.
have entered into this assignment agreement regarding the assignment by the Hospital to the Company of certain intellectual property rights on the terms and conditions set out in the following.
August 11th, 2014 · Common Contracts · 2 similar Forward Pharma a/S – INDEMNIFICATION AGREEMENT This Indemnification Agreement (the “Agreement”) is made and entered into this day of [·], 2014, by and between Forward Pharma A/S, a Danish corporation (the “Company,” which term shall include, where appropriate, any Entity (as hereinafter defined) controlled directly or indirectly by the Company), and [·] (the “Indemnitee”).
This Indemnification Agreement (the “Agreement”) is made and entered into this day of [·], 2014, by and between Forward Pharma A/S, a Danish corporation (the “Company,” which term shall include, where appropriate, any Entity (as hereinafter defined) controlled directly or indirectly by the Company), and [·] (the “Indemnitee”).
August 11th, 2014 · Common Contracts · 2 similar Forward Pharma a/S – EXECUTION VERSION PATENT TRANSFER AGREEMENT BETWEEN Aditech Pharma AG AND Forward Pharma A/S Dated May 4, 2010
April 1st, 2002 · Common Contracts · 2 similar Nn Inc – NN EUROBALL, ApS SHAREHOLDER AGREEMENT
October 4th, 2021 · Common Contracts · 2 similar Zealand Pharma a/S – STRICTLY CONFIDENTIAL - LEGAL PRIVILEGE
March 30th, 2007 · Common Contracts · 2 similar Amicus Therapeutics Inc – WITNESSETH:
February 9th, 2005 Candela Corp /De/ – Contract NOTE: CONFIDENTIAL TREATMENT HAS BEEN OBTAINED OR REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. WHENEVER CONFIDENTIAL INFORMATION IS OMITTED HEREIN (SUCH OMISSIONS ARE DENOTED BY AN ASTERISK), SUCH CONFIDENTIAL INFORMATION HAS BEEN SUBMITTED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT.
NOTE: CONFIDENTIAL TREATMENT HAS BEEN OBTAINED OR REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. WHENEVER CONFIDENTIAL INFORMATION IS OMITTED HEREIN (SUCH OMISSIONS ARE DENOTED BY AN ASTERISK), SUCH CONFIDENTIAL INFORMATION HAS BEEN SUBMITTED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT.
May 15th, 2009 Invitel Holdings a/S – Dated 2009 THIRD SUPPLEMENTAL AGREEMENT relating to a FACILITIES AGREEMENT for Term and Multicurrency Revolving Facilities INVITEL Zrt. Borrower MAGYAR TELECOM B.V. and CERTAIN OF ITS SUBSIDIARIES Guarantors BNP PARIBAS and CALYON Co-ordinators BNP...
February 27th, 2007 Jurak Corp World Wide Inc – Exclusive License and Distribution Agreement between PhytoLab Solutions, Inc. Las Vegas, Nevada 89119-3746 USA (hereinafter referred to as the Distributor) and Nordic Immotech Trading ApS Klldebrogaardsvej 11 D Denmark (hereinafter referred to as the... This agreement Is made December 1, 2005 (the "Effective Date") between PhytoLab Solutions, Inc., a Nevada Corporation, 1181 Crier Drive, Suite C, Las Vegas, Nevada 8911.9-3745, LISA, (the Distributor") and Nordic Imrnotech Trading ApS, Kildebrogaardsvej 11 D, 4622 hlavdrup, Denmark, registration no.
This agreement Is made December 1, 2005 (the "Effective Date") between PhytoLab Solutions, Inc., a Nevada Corporation, 1181 Crier Drive, Suite C, Las Vegas, Nevada 8911.9-3745, LISA, (the Distributor") and Nordic Imrnotech Trading ApS, Kildebrogaardsvej 11 D, 4622 hlavdrup, Denmark, registration no.
July 28th, 2005 Pozen Inc /Nc – DEVELOPMENT, OPTION AND LICENSE AGREEMENT
April 15th, 2010 Bark Group Inc – THIS SHARE PURCHASE AGREEMENT is made 9 April 2010 BETWEEN: and the parties under (ii)-(viii) above are collectively referred to as “Sellers” and the parties under (ii)-(iii) are collectively referred to as the “Principal Shareholders”.
the parties under (ii)-(viii) above are collectively referred to as “Sellers” and the parties under (ii)-(iii) are collectively referred to as the “Principal Shareholders”.
April 4th, 2001 Dataram Corp – AGREEMENT FOR PURCHASE AND SALE OF ASSETS BETWEEN MEMORY CARD TECHNOLOGY, A/S, IN SUSPENSION OF PAYMENTS, AND DATARAM CORPORATION
September 18th, 1998 Cybernet Internet Services International Inc – 2 change the access purchased or withdraw from Ebone by the end of a quarter provided a six months notice has been given to Ebone. In case the Customer disconnects from Ebone before the contract is terminated with due notice, then the Customer shall...
August 16th, 2000 Sauer Danfoss Inc – Exhibit 10.1(ac) TRADEMARK AND TRADE NAME AGREEMENT With effect from May ____, 2000 (hereinafter the Effective Date) the following agreement is made between: Danfoss A/S, a company organized and existing under the laws of Denmark, having its principal...
March 16th, 2009 Sauer Danfoss Inc – Sauer-Danfoss Inc. Loan Agreement (US $ 25,000,000.00) Loan Agreement (the “Agreement”), dated as of 12th of March, 2009, between Danfoss A/S, a Danish corporation (“Lender”) and Sauer-Danfoss Inc., a Delaware corporation (“Borrower”).
Loan Agreement (the “Agreement”), dated as of 12th of March, 2009, between Danfoss A/S, a Danish corporation (“Lender”) and Sauer-Danfoss Inc., a Delaware corporation (“Borrower”).
April 3rd, 2012 Mocon Inc – Vendor Loan Agreement Project Atmosphere have on 9 March 2012 entered into a share purchase agreement (the “SPA”) concerning the Borrower’s acquisition of shares in PBI-Dansensor A/S, CVR-no. 70 60 38 10 (the “Company”). The SPA was amended on 29 March 2012 whereby, inter alia, Borrower’s right to purchase the Shares was assigned to MOCON Denmark Holding ApS, CVR-no. 34 46 73 07, a wholly owned subsidiary of MOCON (“Acquisition Co.”). The Parties have agreed that out of the Purchase Price otherwise payable by Acquisition Co. an amount corresponding to the Vendor Loan (as defined below) shall be settled by Borrower entering into this vendor loan agreement (together with the Security Documents (as defined below) the “Agreement”).
have on 9 March 2012 entered into a share purchase agreement (the “SPA”) concerning the Borrower’s acquisition of shares in PBI-Dansensor A/S, CVR-no. 70 60 38 10 (the “Company”). The SPA was amended on 29 March 2012 whereby, inter alia, Borrower’s right to purchase the Shares was assigned to MOCON Denmark Holding ApS, CVR-no. 34 46 73 07, a wholly owned subsidiary of MOCON (“Acquisition Co.”). The Parties have agreed that out of the Purchase Price otherwise payable by Acquisition Co. an amount corresponding to the Vendor Loan (as defined below) shall be settled by Borrower entering into this vendor loan agreement (together with the Security Documents (as defined below) the “Agreement”).
January 17th, 2017 Forward Pharma a/S – Contract SHAREHOLDERS COMMITMENT AGREEMENT dated as of January 17, 2017 (this “Agreement”), among BIOGEN SWISS MANUFACTURING GMBH, organized and existing under the Laws of Switzerland and having its principal place of business at Landys & Gyr Strasse 3, 6300 Zug, Switzerland (“U.S. Licensee”), BIOGEN INTERNATIONAL HOLDING LTD, organized and existing under the Laws of Bermuda, having its registered office at 22 Victoria Court, Hamilton, Bermuda (“Designated Countries Licensee” and together with U.S. Licensee, “Licensee”), and each of THE PARTIES LISTED ON SCHEDULE A ATTACHED HERETO (each, a “Shareholder” and, collectively, the “Shareholders”).
SHAREHOLDERS COMMITMENT AGREEMENT dated as of January 17, 2017 (this “Agreement”), among BIOGEN SWISS MANUFACTURING GMBH, organized and existing under the Laws of Switzerland and having its principal place of business at Landys & Gyr Strasse 3, 6300 Zug, Switzerland (“U.S. Licensee”), BIOGEN INTERNATIONAL HOLDING LTD, organized and existing under the Laws of Bermuda, having its registered office at 22 Victoria Court, Hamilton, Bermuda (“Designated Countries Licensee” and together with U.S. Licensee, “Licensee”), and each of THE PARTIES LISTED ON SCHEDULE A ATTACHED HERETO (each, a “Shareholder” and, collectively, the “Shareholders”).
April 30th, 2008 Bark Group Inc – Funding Agreement December 2007 have entered into this funding agreement on the terms and conditions set out below (hereinafter referred to as the "Agreement").
have entered into this funding agreement on the terms and conditions set out below (hereinafter referred to as the "Agreement").
October 4th, 2021 Zealand Pharma a/S – STRICTLY CONFIDENTIAL Agreement on restricted share unitS
October 25th, 2013 Oxford Immunotec Global PLC – THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT THIS AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT is entered into as of 22 December, 2009 (the “Amended and Restated Agreement”), between Oxford Immunotec Ltd (“OXFORD”), having its registered office at 94C Milton Park, Abingdon, Oxfordshire, OX14 4RY, United Kingdom and Statens Serum Institut (“SSI”), a governmental enterprise under the laws of the Kingdom of Denmark, with offices at 5, Artillerivej, 2300 Copenhagen S, Denmark.
THIS AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT is entered into as of 22 December, 2009 (the “Amended and Restated Agreement”), between Oxford Immunotec Ltd (“OXFORD”), having its registered office at 94C Milton Park, Abingdon, Oxfordshire, OX14 4RY, United Kingdom and Statens Serum Institut (“SSI”), a governmental enterprise under the laws of the Kingdom of Denmark, with offices at 5, Artillerivej, 2300 Copenhagen S, Denmark.
July 14th, 2017 Vilacto Bio Inc. – Patent License Agreement THIS AGREEMENT (hereinafter referred to as the "Agreement") is made by and between Pharma GP ApS (hereinafter referred to as "Licensor"), a corporation with principal offices at Fabriksvej 48, 4700 Næstved, Denmark, and Vilacto Bio Inc, a limited company with principal offices at The Seagram Building, 375 Park Avenue Suite 2607, New York City NY 10152 U.S.A., (hereinafter referred to as "Licensee").
THIS AGREEMENT (hereinafter referred to as the "Agreement") is made by and between Pharma GP ApS (hereinafter referred to as "Licensor"), a corporation with principal offices at Fabriksvej 48, 4700 Næstved, Denmark, and Vilacto Bio Inc, a limited company with principal offices at The Seagram Building, 375 Park Avenue Suite 2607, New York City NY 10152 U.S.A., (hereinafter referred to as "Licensee").
June 7th, 2004 Trading Solutions Com Inc – LICENSE AND SUPPLY AGREEMENT This License and Supply Agreement (this ”Agreement”) is entered into as of February 3rd,, 2004 (the “Effective Date”) by and between Chembio Diagnostics Systems, Inc., and its Affiliates (“Chembio”) a corporation incorporated under the laws of Delaware and having its registered address at 3661 Horseblock Road, Medford, NY 11763, USA and Statens Serum Institut (“SSI”), a governmental enterprise under the laws of the Kingdom of Denmark with offices at 5, Artillerivej, 2300 Copenhagen S, Denmark.
This License and Supply Agreement (this ”Agreement”) is entered into as of February 3rd,, 2004 (the “Effective Date”) by and between Chembio Diagnostics Systems, Inc., and its Affiliates (“Chembio”) a corporation incorporated under the laws of Delaware and having its registered address at 3661 Horseblock Road, Medford, NY 11763, USA and Statens Serum Institut (“SSI”), a governmental enterprise under the laws of the Kingdom of Denmark with offices at 5, Artillerivej, 2300 Copenhagen S, Denmark.
August 8th, 2019 Savara Inc – AMENDMENT TO THE BUSINESS TRANSFER AGREEMENT BETWEEN SAVARA INC. AND SERENDEX PHARAMCEUTICALS A/S This amendment (“Amendment”) to the Business Transfer Agreement, dated May 13, 2016 (the “Agreement”), between Aravas Inc., formerly Savara Inc. (“Savara”), and Serenova A/S, formerly Serendex Pharmaceuticals A/S (“Serenova”), is made effective as of May [27], 2019 (“Amendment Effective Date”) by and between Savara and Serenova. Savara and Serenova shall be referred to each as a “Party” and collectively as the “Parties.”
This amendment (“Amendment”) to the Business Transfer Agreement, dated May 13, 2016 (the “Agreement”), between Aravas Inc., formerly Savara Inc. (“Savara”), and Serenova A/S, formerly Serendex Pharmaceuticals A/S (“Serenova”), is made effective as of May [27], 2019 (“Amendment Effective Date”) by and between Savara and Serenova. Savara and Serenova shall be referred to each as a “Party” and collectively as the “Parties.”
November 30th, 2006 Wolseley PLC – SHARE SALE AND PURCHASE AGREEMENT 22 July 2006 has been entered into by and between on the one side the Persons set out in Schedule 1 (the “Sellers”) and on the other side Wolseley Holdings Denmark ApS (the “Buyer”) and Wolseley plc (the “Guarantor”)
has been entered into by and between on the one side the Persons set out in Schedule 1 (the “Sellers”) and on the other side Wolseley Holdings Denmark ApS (the “Buyer”) and Wolseley plc (the “Guarantor”)
January 8th, 2001 Primix – SHARE PURCHASE AGREEMENT
April 13th, 2000 Hungarian Telephone & Cable Corp – EUR 130,000,000 SENIOR SECURED DEBT FACILITY AGREEMENT dated April 11, 2000 for HUNGAROTEL TAVKOZLESI KONCESSZIOS RESZVENYTARSASAG RABA-COM TAVKOZLESI KONCESSZIOS RESZVENYTARSASAG PAPA ES TERSEGE TAVKOZLESI KONCESSZIOS RESZVENYTARSASAG KNC...